

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.76980146 |
| 2 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.92163724 |
| 3 | lysine metabolic process (GO:0006553) | 4.64831922 |
| 4 | lysine catabolic process (GO:0006554) | 4.64831922 |
| 5 | short-chain fatty acid metabolic process (GO:0046459) | 4.60931681 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 4.36447694 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.36447694 |
| 8 | fucose catabolic process (GO:0019317) | 4.30047407 |
| 9 | L-fucose metabolic process (GO:0042354) | 4.30047407 |
| 10 | L-fucose catabolic process (GO:0042355) | 4.30047407 |
| 11 | platelet dense granule organization (GO:0060155) | 4.29559865 |
| 12 | behavioral response to nicotine (GO:0035095) | 4.29145251 |
| 13 | fatty acid beta-oxidation (GO:0006635) | 4.26285061 |
| 14 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.24640499 |
| 15 | regulation of sequestering of triglyceride (GO:0010889) | 4.20661830 |
| 16 | carnitine shuttle (GO:0006853) | 4.07285864 |
| 17 | fatty acid oxidation (GO:0019395) | 3.99786614 |
| 18 | fatty acid transmembrane transport (GO:1902001) | 3.99121230 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.96546220 |
| 20 | L-phenylalanine metabolic process (GO:0006558) | 3.96546220 |
| 21 | DNA double-strand break processing (GO:0000729) | 3.94886758 |
| 22 | fatty acid catabolic process (GO:0009062) | 3.92165307 |
| 23 | lipid oxidation (GO:0034440) | 3.88748435 |
| 24 | acetyl-CoA metabolic process (GO:0006084) | 3.85495699 |
| 25 | biotin metabolic process (GO:0006768) | 3.78930354 |
| 26 | cysteine metabolic process (GO:0006534) | 3.77513690 |
| 27 | mannosylation (GO:0097502) | 3.76661876 |
| 28 | tricarboxylic acid metabolic process (GO:0072350) | 3.75091698 |
| 29 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.74289009 |
| 30 | response to pheromone (GO:0019236) | 3.68526911 |
| 31 | response to methylmercury (GO:0051597) | 3.63402644 |
| 32 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.63296226 |
| 33 | valine metabolic process (GO:0006573) | 3.58020404 |
| 34 | protein complex biogenesis (GO:0070271) | 3.55780080 |
| 35 | aspartate family amino acid catabolic process (GO:0009068) | 3.49451299 |
| 36 | NADH metabolic process (GO:0006734) | 3.48820641 |
| 37 | inositol phosphate catabolic process (GO:0071545) | 3.48446479 |
| 38 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.47745982 |
| 39 | carnitine transport (GO:0015879) | 3.47166889 |
| 40 | amino-acid betaine transport (GO:0015838) | 3.47166889 |
| 41 | monocarboxylic acid catabolic process (GO:0072329) | 3.45817234 |
| 42 | respiratory chain complex IV assembly (GO:0008535) | 3.42545972 |
| 43 | acyl-CoA biosynthetic process (GO:0071616) | 3.41932161 |
| 44 | thioester biosynthetic process (GO:0035384) | 3.41932161 |
| 45 | cytidine metabolic process (GO:0046087) | 3.39540875 |
| 46 | cytidine catabolic process (GO:0006216) | 3.39540875 |
| 47 | cytidine deamination (GO:0009972) | 3.39540875 |
| 48 | carnitine transmembrane transport (GO:1902603) | 3.37974130 |
| 49 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.36672978 |
| 50 | branched-chain amino acid metabolic process (GO:0009081) | 3.32891494 |
| 51 | ketone body metabolic process (GO:1902224) | 3.32058351 |
| 52 | replication fork processing (GO:0031297) | 3.31699389 |
| 53 | negative regulation of mast cell activation (GO:0033004) | 3.31111250 |
| 54 | regulation of fatty acid oxidation (GO:0046320) | 3.30801083 |
| 55 | indolalkylamine metabolic process (GO:0006586) | 3.27504608 |
| 56 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.27501458 |
| 57 | ubiquinone biosynthetic process (GO:0006744) | 3.27176188 |
| 58 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.26037698 |
| 59 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.26037698 |
| 60 | NADH dehydrogenase complex assembly (GO:0010257) | 3.26037698 |
| 61 | branched-chain amino acid catabolic process (GO:0009083) | 3.24743663 |
| 62 | positive regulation of fatty acid oxidation (GO:0046321) | 3.24298259 |
| 63 | drug transmembrane transport (GO:0006855) | 3.24185086 |
| 64 | indole-containing compound catabolic process (GO:0042436) | 3.23441530 |
| 65 | indolalkylamine catabolic process (GO:0046218) | 3.23441530 |
| 66 | tryptophan catabolic process (GO:0006569) | 3.23441530 |
| 67 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.22004717 |
| 68 | tricarboxylic acid cycle (GO:0006099) | 3.21876006 |
| 69 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.21482594 |
| 70 | protein-cofactor linkage (GO:0018065) | 3.21479969 |
| 71 | succinate metabolic process (GO:0006105) | 3.20928768 |
| 72 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.20418836 |
| 73 | alpha-linolenic acid metabolic process (GO:0036109) | 3.17247732 |
| 74 | protein K11-linked deubiquitination (GO:0035871) | 3.16852352 |
| 75 | triglyceride catabolic process (GO:0019433) | 3.16426025 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 3.14740127 |
| 77 | ubiquinone metabolic process (GO:0006743) | 3.14215918 |
| 78 | detection of light stimulus involved in visual perception (GO:0050908) | 3.14138524 |
| 79 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.14138524 |
| 80 | aromatic amino acid family catabolic process (GO:0009074) | 3.13364053 |
| 81 | inositol phosphate dephosphorylation (GO:0046855) | 3.13238992 |
| 82 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.13238992 |
| 83 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.13060102 |
| 84 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.11636375 |
| 85 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.09364230 |
| 86 | quaternary ammonium group transport (GO:0015697) | 3.09256622 |
| 87 | regulation of triglyceride catabolic process (GO:0010896) | 3.09205764 |
| 88 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.08505591 |
| 89 | multicellular organism reproduction (GO:0032504) | 3.05629748 |
| 90 | neutral lipid catabolic process (GO:0046461) | 3.04686335 |
| 91 | acylglycerol catabolic process (GO:0046464) | 3.04686335 |
| 92 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.03224658 |
| 93 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.03224658 |
| 94 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.03042022 |
| 95 | organelle membrane fusion (GO:0090174) | 3.01528856 |
| 96 | protein deneddylation (GO:0000338) | 3.01502092 |
| 97 | glyoxylate metabolic process (GO:0046487) | 3.01199624 |
| 98 | cytochrome complex assembly (GO:0017004) | 2.99438485 |
| 99 | C-terminal protein lipidation (GO:0006501) | 2.99304082 |
| 100 | sulfation (GO:0051923) | 2.98981939 |
| 101 | tetrapyrrole biosynthetic process (GO:0033014) | 2.98525231 |
| 102 | proteasome assembly (GO:0043248) | 2.96745223 |
| 103 | acyl-CoA metabolic process (GO:0006637) | 2.96720869 |
| 104 | thioester metabolic process (GO:0035383) | 2.96720869 |
| 105 | prenylation (GO:0097354) | 2.96681526 |
| 106 | protein prenylation (GO:0018342) | 2.96681526 |
| 107 | C-terminal protein amino acid modification (GO:0018410) | 2.94752427 |
| 108 | signal peptide processing (GO:0006465) | 2.94719936 |
| 109 | kynurenine metabolic process (GO:0070189) | 2.91868091 |
| 110 | heme biosynthetic process (GO:0006783) | 2.91334741 |
| 111 | tryptophan metabolic process (GO:0006568) | 2.90680707 |
| 112 | protein neddylation (GO:0045116) | 2.89623817 |
| 113 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.89332723 |
| 114 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.89158626 |
| 115 | cullin deneddylation (GO:0010388) | 2.88972642 |
| 116 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.87012903 |
| 117 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.84551135 |
| 118 | response to phenylpropanoid (GO:0080184) | 2.84134945 |
| 119 | polyol catabolic process (GO:0046174) | 2.83884316 |
| 120 | positive regulation of prostaglandin secretion (GO:0032308) | 2.83724366 |
| 121 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.83488318 |
| 122 | myelin maintenance (GO:0043217) | 2.83326216 |
| 123 | positive regulation of defense response to virus by host (GO:0002230) | 2.82468806 |
| 124 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.80847861 |
| 125 | GPI anchor metabolic process (GO:0006505) | 2.80843082 |
| 126 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.79885629 |
| 127 | triglyceride biosynthetic process (GO:0019432) | 2.78569902 |
| 128 | pseudouridine synthesis (GO:0001522) | 2.78343293 |
| 129 | response to mercury ion (GO:0046689) | 2.77760374 |
| 130 | intracellular lipid transport (GO:0032365) | 2.77725783 |
| 131 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.77469886 |
| 132 | DNA demethylation (GO:0080111) | 2.77342454 |
| 133 | oxidative demethylation (GO:0070989) | 2.77207549 |
| 134 | adenosine metabolic process (GO:0046085) | 2.76682803 |
| 135 | L-methionine salvage (GO:0071267) | 2.76466546 |
| 136 | L-methionine biosynthetic process (GO:0071265) | 2.76466546 |
| 137 | amino acid salvage (GO:0043102) | 2.76466546 |
| 138 | glycine transport (GO:0015816) | 2.76132037 |
| 139 | recombinational repair (GO:0000725) | 2.74336842 |
| 140 | double-strand break repair via homologous recombination (GO:0000724) | 2.74205245 |
| 141 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.73913258 |
| 142 | porphyrin-containing compound metabolic process (GO:0006778) | 2.73343011 |
| 143 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.72993198 |
| 144 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.72993198 |
| 145 | amino-acid betaine metabolic process (GO:0006577) | 2.72632419 |
| 146 | ethanol oxidation (GO:0006069) | 2.71278429 |
| 147 | neutral lipid biosynthetic process (GO:0046460) | 2.70678252 |
| 148 | acylglycerol biosynthetic process (GO:0046463) | 2.70678252 |
| 149 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.69270358 |
| 150 | regulation of cilium movement (GO:0003352) | 2.69152874 |
| 151 | cellular ketone body metabolic process (GO:0046950) | 2.67159563 |
| 152 | protein localization to endosome (GO:0036010) | 2.66258730 |
| 153 | tRNA processing (GO:0008033) | 2.65629213 |
| 154 | response to lead ion (GO:0010288) | 2.65078707 |
| 155 | piRNA metabolic process (GO:0034587) | 2.64725155 |
| 156 | regulation of cholesterol metabolic process (GO:0090181) | 2.63607144 |
| 157 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.63163472 |
| 158 | maturation of 5.8S rRNA (GO:0000460) | 2.62761089 |
| 159 | neural tube formation (GO:0001841) | 2.62714050 |
| 160 | transcytosis (GO:0045056) | 2.62270502 |
| 161 | triglyceride metabolic process (GO:0006641) | 2.61801216 |
| 162 | negative regulation of telomere maintenance (GO:0032205) | 2.61339326 |
| 163 | peptidyl-histidine modification (GO:0018202) | 2.61238770 |
| 164 | carnitine metabolic process (GO:0009437) | 2.61183075 |
| 165 | regulation of cofactor metabolic process (GO:0051193) | 2.60764735 |
| 166 | regulation of coenzyme metabolic process (GO:0051196) | 2.60764735 |
| 167 | positive regulation of lipid catabolic process (GO:0050996) | 2.60532585 |
| 168 | creatine metabolic process (GO:0006600) | 2.60424882 |
| 169 | methionine biosynthetic process (GO:0009086) | 2.59798278 |
| 170 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.58822275 |
| 171 | intra-S DNA damage checkpoint (GO:0031573) | 2.58331383 |
| 172 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.58192509 |
| 173 | organic acid catabolic process (GO:0016054) | 2.57134348 |
| 174 | carboxylic acid catabolic process (GO:0046395) | 2.57134348 |
| 175 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.56290925 |
| 176 | glutamate metabolic process (GO:0006536) | 2.56265854 |
| 177 | glycerolipid catabolic process (GO:0046503) | 2.55331105 |
| 178 | anterograde synaptic vesicle transport (GO:0048490) | 2.55298876 |
| 179 | protein K6-linked ubiquitination (GO:0085020) | 2.53648681 |
| 180 | rRNA modification (GO:0000154) | 2.52214404 |
| 181 | negative regulation of neurotransmitter transport (GO:0051589) | 2.51629844 |
| 182 | acylglycerol metabolic process (GO:0006639) | 2.51588460 |
| 183 | neutral lipid metabolic process (GO:0006638) | 2.50824422 |
| 184 | low-density lipoprotein particle clearance (GO:0034383) | 2.49193071 |
| 185 | S-adenosylmethionine metabolic process (GO:0046500) | 2.48981368 |
| 186 | quinone biosynthetic process (GO:1901663) | 2.48873595 |
| 187 | axon ensheathment in central nervous system (GO:0032291) | 2.48869300 |
| 188 | central nervous system myelination (GO:0022010) | 2.48869300 |
| 189 | heme metabolic process (GO:0042168) | 2.48386599 |
| 190 | DNA dealkylation (GO:0035510) | 2.47859157 |
| 191 | negative regulation of lipase activity (GO:0060192) | 2.47544913 |
| 192 | regulation of memory T cell differentiation (GO:0043380) | 2.46735561 |
| 193 | very long-chain fatty acid metabolic process (GO:0000038) | 2.45899698 |
| 194 | negative regulation of digestive system process (GO:0060457) | 2.45584197 |
| 195 | positive regulation of glycolytic process (GO:0045821) | 2.43579763 |
| 196 | regulation of sulfur metabolic process (GO:0042762) | 2.40360052 |
| 197 | autophagic vacuole fusion (GO:0000046) | 2.39973771 |
| 198 | GPI anchor biosynthetic process (GO:0006506) | 2.39960730 |
| 199 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.39890259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.11782501 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.42318459 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.39276874 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.56543298 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.30083105 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.01825368 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.00160241 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.91439762 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.70402893 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.69747219 |
| 11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.62909997 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.58938943 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.57081929 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.51805573 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.45621701 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.29068609 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.28066810 |
| 18 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.27736355 |
| 19 | GATA1_19941826_ChIP-Seq_K562_Human | 2.27733954 |
| 20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.15109462 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.12214017 |
| 22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.10556717 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.07902680 |
| 24 | EWS_26573619_Chip-Seq_HEK293_Human | 2.02408404 |
| 25 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.00179713 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.98639713 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.87806436 |
| 28 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.85541628 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.83474651 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.79880206 |
| 31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.75400828 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.74791741 |
| 33 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.73147113 |
| 34 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.71597649 |
| 35 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.68971316 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68638212 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.68197938 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.65572549 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.64498033 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.64052810 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.63604782 |
| 42 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.62924749 |
| 43 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.62571018 |
| 44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.60396075 |
| 45 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.60019875 |
| 46 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.59926942 |
| 47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.59008583 |
| 48 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.58699786 |
| 49 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.57457588 |
| 50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.56072557 |
| 51 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.53387522 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.51803389 |
| 53 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.50469341 |
| 54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.48142696 |
| 55 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.47364352 |
| 56 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.46867220 |
| 57 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.46867220 |
| 58 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.45985100 |
| 59 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.45985100 |
| 60 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.45197391 |
| 61 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.44495332 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43590129 |
| 63 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.42061536 |
| 64 | GATA2_19941826_ChIP-Seq_K562_Human | 1.41614548 |
| 65 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.38937464 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38613686 |
| 67 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.38446533 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36956254 |
| 69 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.36881991 |
| 70 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.36606139 |
| 71 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36252585 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36000446 |
| 73 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33014539 |
| 74 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.32175945 |
| 75 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.32175945 |
| 76 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.31882047 |
| 77 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31170463 |
| 78 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.30220261 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30076465 |
| 80 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29502243 |
| 81 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.29459073 |
| 82 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.29450406 |
| 83 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.29450406 |
| 84 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.26989470 |
| 85 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.26785063 |
| 86 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.26466758 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26072226 |
| 88 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.24593007 |
| 89 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24469884 |
| 90 | AR_20517297_ChIP-Seq_VCAP_Human | 1.24336218 |
| 91 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24055687 |
| 92 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23971962 |
| 93 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.21181248 |
| 94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20884086 |
| 95 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.20819043 |
| 96 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.20267174 |
| 97 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19517972 |
| 98 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18793664 |
| 99 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.18000162 |
| 100 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.17981335 |
| 101 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.17534946 |
| 102 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17448323 |
| 103 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.17430830 |
| 104 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17335695 |
| 105 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.16730730 |
| 106 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.16444413 |
| 107 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15181986 |
| 108 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14878510 |
| 109 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14598429 |
| 110 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.14493521 |
| 111 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14365292 |
| 112 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.14234781 |
| 113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14011678 |
| 114 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.14008455 |
| 115 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.13984878 |
| 116 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.12563736 |
| 117 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12294321 |
| 118 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12058613 |
| 119 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.10869709 |
| 120 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.10677701 |
| 121 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.09189090 |
| 122 | NCOR_22424771_ChIP-Seq_293T_Human | 1.08433927 |
| 123 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08265506 |
| 124 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08077468 |
| 125 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07202052 |
| 126 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.07101071 |
| 127 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06873084 |
| 128 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06754042 |
| 129 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06355179 |
| 130 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06191270 |
| 131 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06162234 |
| 132 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.06088231 |
| 133 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05085807 |
| 134 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05033120 |
| 135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05033120 |
| 136 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04474996 |
| 137 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.04322335 |
| 138 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03849750 |
| 139 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02769246 |
| 140 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02769246 |
| 141 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02130010 |
| 142 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.01629740 |
| 143 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.00681853 |
| 144 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.00579428 |
| 145 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.00450006 |
| 146 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.00245859 |
| 147 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.00072192 |
| 148 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98735339 |
| 149 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98173812 |
| 150 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.98157804 |
| 151 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97727461 |
| 152 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97612597 |
| 153 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.97263940 |
| 154 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97083774 |
| 155 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96485062 |
| 156 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95612967 |
| 157 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95486845 |
| 158 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95344204 |
| 159 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95124994 |
| 160 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.94317267 |
| 161 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94041454 |
| 162 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94012206 |
| 163 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93940251 |
| 164 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93429065 |
| 165 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.93230635 |
| 166 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.92878037 |
| 167 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.92260011 |
| 168 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90242563 |
| 169 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90077768 |
| 170 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89544532 |
| 171 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89431326 |
| 172 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88977721 |
| 173 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88862453 |
| 174 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87659906 |
| 175 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86725665 |
| 176 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86214403 |
| 177 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.84773216 |
| 178 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84031127 |
| 179 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83924849 |
| 180 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83664301 |
| 181 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.82897256 |
| 182 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.80540639 |
| 183 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.79074688 |
| 184 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.78796713 |
| 185 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.77855163 |
| 186 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.77320447 |
| 187 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.76660955 |
| 188 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.76641198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.92924166 |
| 2 | MP0005360_urolithiasis | 3.71143105 |
| 3 | MP0003656_abnormal_erythrocyte_physiolo | 3.31914795 |
| 4 | MP0004130_abnormal_muscle_cell | 3.14575942 |
| 5 | MP0004147_increased_porphyrin_level | 3.10100905 |
| 6 | MP0005365_abnormal_bile_salt | 2.95574068 |
| 7 | MP0004185_abnormal_adipocyte_glucose | 2.89607183 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.84704588 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.81174759 |
| 10 | MP0005083_abnormal_biliary_tract | 2.79545991 |
| 11 | MP0005666_abnormal_adipose_tissue | 2.69398858 |
| 12 | MP0004043_abnormal_pH_regulation | 2.66805233 |
| 13 | MP0008877_abnormal_DNA_methylation | 2.55187514 |
| 14 | MP0005670_abnormal_white_adipose | 2.54182962 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.49653014 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.47019047 |
| 17 | MP0003195_calcinosis | 2.39790569 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.27815636 |
| 19 | MP0005332_abnormal_amino_acid | 2.27303758 |
| 20 | MP0000372_irregular_coat_pigmentation | 2.26594727 |
| 21 | MP0002638_abnormal_pupillary_reflex | 2.25890789 |
| 22 | MP0002971_abnormal_brown_adipose | 2.21551208 |
| 23 | MP0002102_abnormal_ear_morphology | 2.21181424 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.17696046 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 2.15472404 |
| 26 | MP0005535_abnormal_body_temperature | 2.14216291 |
| 27 | MP0001666_abnormal_nutrient_absorption | 2.14192281 |
| 28 | MP0005375_adipose_tissue_phenotype | 2.08910272 |
| 29 | MP0002234_abnormal_pharynx_morphology | 2.08479858 |
| 30 | MP0005075_abnormal_melanosome_morpholog | 2.04264441 |
| 31 | MP0005174_abnormal_tail_pigmentation | 2.01433737 |
| 32 | MP0008058_abnormal_DNA_repair | 1.98269273 |
| 33 | MP0005551_abnormal_eye_electrophysiolog | 1.97022398 |
| 34 | MP0003646_muscle_fatigue | 1.96994715 |
| 35 | MP0003950_abnormal_plasma_membrane | 1.96177325 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.93133403 |
| 37 | MP0006072_abnormal_retinal_apoptosis | 1.92672534 |
| 38 | MP0003252_abnormal_bile_duct | 1.91769792 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.89401146 |
| 40 | MP0008872_abnormal_physiological_respon | 1.88111807 |
| 41 | MP0005253_abnormal_eye_physiology | 1.83167472 |
| 42 | MP0000015_abnormal_ear_pigmentation | 1.81765633 |
| 43 | MP0000920_abnormal_myelination | 1.77840355 |
| 44 | MP0000003_abnormal_adipose_tissue | 1.75118325 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.70252789 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 1.70053217 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64486205 |
| 48 | MP0001968_abnormal_touch/_nociception | 1.64019892 |
| 49 | MP0002160_abnormal_reproductive_system | 1.61744254 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 1.61650566 |
| 51 | MP0000013_abnormal_adipose_tissue | 1.60656491 |
| 52 | MP0000427_abnormal_hair_cycle | 1.54473534 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.50984299 |
| 54 | MP0003011_delayed_dark_adaptation | 1.50267374 |
| 55 | MP0003186_abnormal_redox_activity | 1.49303039 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 1.48210541 |
| 57 | MP0005410_abnormal_fertilization | 1.47761656 |
| 58 | MP0005334_abnormal_fat_pad | 1.47397111 |
| 59 | MP0003718_maternal_effect | 1.46758088 |
| 60 | MP0001529_abnormal_vocalization | 1.46209741 |
| 61 | MP0005646_abnormal_pituitary_gland | 1.45419100 |
| 62 | MP0005389_reproductive_system_phenotype | 1.44759853 |
| 63 | MP0001661_extended_life_span | 1.43974576 |
| 64 | MP0005671_abnormal_response_to | 1.43269607 |
| 65 | MP0002163_abnormal_gland_morphology | 1.39864066 |
| 66 | MP0000609_abnormal_liver_physiology | 1.39678107 |
| 67 | MP0003959_abnormal_lean_body | 1.37375967 |
| 68 | MP0002876_abnormal_thyroid_physiology | 1.37339592 |
| 69 | MP0004142_abnormal_muscle_tone | 1.37067001 |
| 70 | MP0002928_abnormal_bile_duct | 1.36335001 |
| 71 | MP0002095_abnormal_skin_pigmentation | 1.35450811 |
| 72 | MP0003300_gastrointestinal_ulcer | 1.35187567 |
| 73 | MP0002909_abnormal_adrenal_gland | 1.33452089 |
| 74 | MP0001986_abnormal_taste_sensitivity | 1.31612666 |
| 75 | MP0005636_abnormal_mineral_homeostasis | 1.28184008 |
| 76 | MP0003329_amyloid_beta_deposits | 1.26218132 |
| 77 | MP0001756_abnormal_urination | 1.24709650 |
| 78 | MP0003690_abnormal_glial_cell | 1.22606559 |
| 79 | MP0000747_muscle_weakness | 1.21390711 |
| 80 | MP0001765_abnormal_ion_homeostasis | 1.20913075 |
| 81 | MP0006276_abnormal_autonomic_nervous | 1.19531772 |
| 82 | MP0000538_abnormal_urinary_bladder | 1.19088494 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 1.19014503 |
| 84 | MP0001919_abnormal_reproductive_system | 1.17574977 |
| 85 | MP0001764_abnormal_homeostasis | 1.17188269 |
| 86 | MP0005448_abnormal_energy_balance | 1.13961840 |
| 87 | MP0009697_abnormal_copulation | 1.13865099 |
| 88 | MP0005409_darkened_coat_color | 1.13265093 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 1.12953607 |
| 90 | MP0003868_abnormal_feces_composition | 1.12922761 |
| 91 | MP0009046_muscle_twitch | 1.10819120 |
| 92 | MP0006054_spinal_hemorrhage | 1.10409282 |
| 93 | MP0002736_abnormal_nociception_after | 1.09432338 |
| 94 | MP0001905_abnormal_dopamine_level | 1.09067867 |
| 95 | MP0006035_abnormal_mitochondrial_morpho | 1.08619775 |
| 96 | MP0002970_abnormal_white_adipose | 1.08510431 |
| 97 | MP0001879_abnormal_lymphatic_vessel | 1.06245602 |
| 98 | MP0003786_premature_aging | 1.06200207 |
| 99 | MP0000230_abnormal_systemic_arterial | 1.03234041 |
| 100 | MP0009840_abnormal_foam_cell | 1.02260494 |
| 101 | MP0001944_abnormal_pancreas_morphology | 1.01766658 |
| 102 | MP0002822_catalepsy | 1.00934441 |
| 103 | MP0005330_cardiomyopathy | 1.00861525 |
| 104 | MP0005452_abnormal_adipose_tissue | 0.99887369 |
| 105 | MP0002938_white_spotting | 0.99194751 |
| 106 | MP0005367_renal/urinary_system_phenotyp | 0.98261531 |
| 107 | MP0000516_abnormal_urinary_system | 0.98261531 |
| 108 | MP0005645_abnormal_hypothalamus_physiol | 0.96081563 |
| 109 | MP0005220_abnormal_exocrine_pancreas | 0.94694318 |
| 110 | MP0002148_abnormal_hypersensitivity_rea | 0.93584857 |
| 111 | MP0010368_abnormal_lymphatic_system | 0.92721482 |
| 112 | MP0000371_diluted_coat_color | 0.92266667 |
| 113 | MP0002751_abnormal_autonomic_nervous | 0.91764762 |
| 114 | MP0009764_decreased_sensitivity_to | 0.91379887 |
| 115 | MP0001835_abnormal_antigen_presentation | 0.90450662 |
| 116 | MP0003136_yellow_coat_color | 0.90097159 |
| 117 | MP0005084_abnormal_gallbladder_morpholo | 0.90081085 |
| 118 | MP0001324_abnormal_eye_pigmentation | 0.89744167 |
| 119 | MP0003787_abnormal_imprinting | 0.89390725 |
| 120 | MP0005195_abnormal_posterior_eye | 0.86605942 |
| 121 | MP0002972_abnormal_cardiac_muscle | 0.86140329 |
| 122 | MP0003045_fibrosis | 0.85993879 |
| 123 | MP0004084_abnormal_cardiac_muscle | 0.85979276 |
| 124 | MP0004270_analgesia | 0.85826378 |
| 125 | MP0003953_abnormal_hormone_level | 0.85677312 |
| 126 | MP0005319_abnormal_enzyme/_coenzyme | 0.85507432 |
| 127 | MP0000358_abnormal_cell_content/ | 0.85307235 |
| 128 | MP0008775_abnormal_heart_ventricle | 0.85242190 |
| 129 | MP0001929_abnormal_gametogenesis | 0.84510712 |
| 130 | MP0004215_abnormal_myocardial_fiber | 0.84502018 |
| 131 | MP0004859_abnormal_synaptic_plasticity | 0.84236256 |
| 132 | MP0005187_abnormal_penis_morphology | 0.83017864 |
| 133 | MP0001984_abnormal_olfaction | 0.82166366 |
| 134 | MP0004484_altered_response_of | 0.81697820 |
| 135 | MP0004085_abnormal_heartbeat | 0.81694653 |
| 136 | MP0009785_altered_susceptibility_to | 0.81407759 |
| 137 | MP0002693_abnormal_pancreas_physiology | 0.80542077 |
| 138 | MP0000751_myopathy | 0.80408683 |
| 139 | MP0005266_abnormal_metabolism | 0.79915895 |
| 140 | MP0004885_abnormal_endolymph | 0.79744359 |
| 141 | MP0009115_abnormal_fat_cell | 0.78593692 |
| 142 | MP0003633_abnormal_nervous_system | 0.77649901 |
| 143 | MP0003724_increased_susceptibility_to | 0.77378076 |
| 144 | MP0004019_abnormal_vitamin_homeostasis | 0.77136678 |
| 145 | MP0005620_abnormal_muscle_contractility | 0.74632690 |
| 146 | MP0004087_abnormal_muscle_fiber | 0.74556107 |
| 147 | MP0005386_behavior/neurological_phenoty | 0.74288945 |
| 148 | MP0004924_abnormal_behavior | 0.74288945 |
| 149 | MP0004036_abnormal_muscle_relaxation | 0.73134680 |
| 150 | MP0000653_abnormal_sex_gland | 0.72639003 |
| 151 | MP0000604_amyloidosis | 0.72477567 |
| 152 | MP0002272_abnormal_nervous_system | 0.71246534 |
| 153 | MP0008057_abnormal_DNA_replication | 0.70652109 |
| 154 | MP0005058_abnormal_lysosome_morphology | 0.68724339 |
| 155 | MP0001958_emphysema | 0.67173978 |
| 156 | MP0004272_abnormal_basement_membrane | 0.66968377 |
| 157 | MP0009642_abnormal_blood_homeostasis | 0.65700622 |
| 158 | MP0005451_abnormal_body_composition | 0.65558249 |
| 159 | MP0002136_abnormal_kidney_physiology | 0.64817463 |
| 160 | MP0002069_abnormal_eating/drinking_beha | 0.64726302 |
| 161 | MP0001177_atelectasis | 0.63142753 |
| 162 | MP0005379_endocrine/exocrine_gland_phen | 0.63091587 |
| 163 | MP0002064_seizures | 0.62856543 |
| 164 | MP0003635_abnormal_synaptic_transmissio | 0.62620219 |
| 165 | MP0003221_abnormal_cardiomyocyte_apopto | 0.61632717 |
| 166 | MP0001544_abnormal_cardiovascular_syste | 0.60535724 |
| 167 | MP0005385_cardiovascular_system_phenoty | 0.60535724 |
| 168 | MP0006138_congestive_heart_failure | 0.60384973 |
| 169 | MP0010386_abnormal_urinary_bladder | 0.59709054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.85688782 |
| 2 | Ketoacidosis (HP:0001993) | 4.36707722 |
| 3 | Ketosis (HP:0001946) | 4.08554953 |
| 4 | Hyperglycinuria (HP:0003108) | 3.96342235 |
| 5 | Pancreatic cysts (HP:0001737) | 3.73842528 |
| 6 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.72342550 |
| 7 | Poikilocytosis (HP:0004447) | 3.71265379 |
| 8 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.63083184 |
| 9 | Abnormality of glycine metabolism (HP:0010895) | 3.63083184 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.54836610 |
| 11 | Congenital stationary night blindness (HP:0007642) | 3.38517635 |
| 12 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.37489022 |
| 13 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.37489022 |
| 14 | Dicarboxylic aciduria (HP:0003215) | 3.31977556 |
| 15 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.31977556 |
| 16 | Type II lissencephaly (HP:0007260) | 3.26792247 |
| 17 | 3-Methylglutaconic aciduria (HP:0003535) | 3.21685300 |
| 18 | Hypothermia (HP:0002045) | 3.20759491 |
| 19 | Abnormality of midbrain morphology (HP:0002418) | 3.18796393 |
| 20 | Molar tooth sign on MRI (HP:0002419) | 3.18796393 |
| 21 | Generalized aminoaciduria (HP:0002909) | 3.14226532 |
| 22 | Increased circulating renin level (HP:0000848) | 3.10104478 |
| 23 | Mitochondrial inheritance (HP:0001427) | 3.08820168 |
| 24 | Increased CSF lactate (HP:0002490) | 3.07582518 |
| 25 | Gout (HP:0001997) | 3.06368418 |
| 26 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.02753446 |
| 27 | Acute necrotizing encephalopathy (HP:0006965) | 2.94560118 |
| 28 | True hermaphroditism (HP:0010459) | 2.94476314 |
| 29 | Hypochromic microcytic anemia (HP:0004840) | 2.92830754 |
| 30 | Abnormality of the renal cortex (HP:0011035) | 2.91774280 |
| 31 | Hypokalemic alkalosis (HP:0001949) | 2.89220916 |
| 32 | Acanthocytosis (HP:0001927) | 2.88819748 |
| 33 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.88063522 |
| 34 | Abnormal protein glycosylation (HP:0012346) | 2.88063522 |
| 35 | Abnormal glycosylation (HP:0012345) | 2.88063522 |
| 36 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.88063522 |
| 37 | Progressive macrocephaly (HP:0004481) | 2.87475073 |
| 38 | Hepatocellular necrosis (HP:0001404) | 2.83726127 |
| 39 | Abnormal gallbladder morphology (HP:0012437) | 2.82921501 |
| 40 | Hyperammonemia (HP:0001987) | 2.82055292 |
| 41 | Nephronophthisis (HP:0000090) | 2.81352303 |
| 42 | Myoglobinuria (HP:0002913) | 2.81285978 |
| 43 | Cerebral hemorrhage (HP:0001342) | 2.80791644 |
| 44 | Cholelithiasis (HP:0001081) | 2.80167499 |
| 45 | Pancreatic fibrosis (HP:0100732) | 2.79221930 |
| 46 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.78882483 |
| 47 | Metabolic alkalosis (HP:0200114) | 2.78577720 |
| 48 | Abnormality of alanine metabolism (HP:0010916) | 2.72816711 |
| 49 | Hyperalaninemia (HP:0003348) | 2.72816711 |
| 50 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.72816711 |
| 51 | Acute encephalopathy (HP:0006846) | 2.71961826 |
| 52 | Limb hypertonia (HP:0002509) | 2.69403863 |
| 53 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.69008881 |
| 54 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.68292026 |
| 55 | Xanthomatosis (HP:0000991) | 2.66805187 |
| 56 | Pheochromocytoma (HP:0002666) | 2.64565777 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.64436604 |
| 58 | Medial flaring of the eyebrow (HP:0010747) | 2.63336750 |
| 59 | Inability to walk (HP:0002540) | 2.62683462 |
| 60 | Abnormality of macular pigmentation (HP:0008002) | 2.61582275 |
| 61 | Proximal tubulopathy (HP:0000114) | 2.61421443 |
| 62 | Hyperactive renin-angiotensin system (HP:0000841) | 2.59807319 |
| 63 | Attenuation of retinal blood vessels (HP:0007843) | 2.57770030 |
| 64 | Increased hepatocellular lipid droplets (HP:0006565) | 2.57262180 |
| 65 | Type I transferrin isoform profile (HP:0003642) | 2.57186090 |
| 66 | Hyperglycinemia (HP:0002154) | 2.56627098 |
| 67 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56525362 |
| 68 | Lipid accumulation in hepatocytes (HP:0006561) | 2.56221769 |
| 69 | Metabolic acidosis (HP:0001942) | 2.54177185 |
| 70 | Deep venous thrombosis (HP:0002625) | 2.49835699 |
| 71 | Hyperbilirubinemia (HP:0002904) | 2.46527267 |
| 72 | Chronic hepatic failure (HP:0100626) | 2.43723376 |
| 73 | Renal Fanconi syndrome (HP:0001994) | 2.43302803 |
| 74 | Increased serum lactate (HP:0002151) | 2.42390451 |
| 75 | Abnormality of purine metabolism (HP:0004352) | 2.42252741 |
| 76 | Abnormality of the renal medulla (HP:0100957) | 2.41963150 |
| 77 | Methylmalonic acidemia (HP:0002912) | 2.41489652 |
| 78 | Oligomenorrhea (HP:0000876) | 2.40619995 |
| 79 | Abnormal biliary tract physiology (HP:0012439) | 2.39794921 |
| 80 | Bile duct proliferation (HP:0001408) | 2.39794921 |
| 81 | Cerebellar dysplasia (HP:0007033) | 2.38121844 |
| 82 | Neurofibrillary tangles (HP:0002185) | 2.37246039 |
| 83 | Progressive inability to walk (HP:0002505) | 2.36183545 |
| 84 | Large for gestational age (HP:0001520) | 2.35975392 |
| 85 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.35316729 |
| 86 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.32919156 |
| 87 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.31890144 |
| 88 | Lactic acidosis (HP:0003128) | 2.30752706 |
| 89 | Tachypnea (HP:0002789) | 2.30613311 |
| 90 | Abnormality of the pons (HP:0007361) | 2.27945849 |
| 91 | Thyroiditis (HP:0100646) | 2.26108977 |
| 92 | Hyperlipoproteinemia (HP:0010980) | 2.24695532 |
| 93 | Hydroxyprolinuria (HP:0003080) | 2.24355752 |
| 94 | Abnormality of proline metabolism (HP:0010907) | 2.24355752 |
| 95 | Hepatic necrosis (HP:0002605) | 2.24102685 |
| 96 | Type 2 muscle fiber atrophy (HP:0003554) | 2.22866208 |
| 97 | Chorioretinal atrophy (HP:0000533) | 2.21735407 |
| 98 | Hyperuricemia (HP:0002149) | 2.20721646 |
| 99 | Increased purine levels (HP:0004368) | 2.20721646 |
| 100 | Hypomagnesemia (HP:0002917) | 2.20683298 |
| 101 | Reticulocytosis (HP:0001923) | 2.20209118 |
| 102 | Short tibia (HP:0005736) | 2.18329681 |
| 103 | Hypoplasia of the pons (HP:0012110) | 2.14961191 |
| 104 | Abnormality of renin-angiotensin system (HP:0000847) | 2.14460374 |
| 105 | Neuroendocrine neoplasm (HP:0100634) | 2.14216038 |
| 106 | Cerebral inclusion bodies (HP:0100314) | 2.13732355 |
| 107 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.11350472 |
| 108 | Conjunctival hamartoma (HP:0100780) | 2.10903732 |
| 109 | Diaphragmatic weakness (HP:0009113) | 2.10464585 |
| 110 | Abnormality of chloride homeostasis (HP:0011422) | 2.10050641 |
| 111 | Abnormal drinking behavior (HP:0030082) | 2.09384961 |
| 112 | Polydipsia (HP:0001959) | 2.09384961 |
| 113 | Abnormality of the gallbladder (HP:0005264) | 2.09241652 |
| 114 | Insomnia (HP:0100785) | 2.08438748 |
| 115 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.08003980 |
| 116 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.08003980 |
| 117 | Disproportionate short-trunk short stature (HP:0003521) | 2.05297623 |
| 118 | Intrahepatic cholestasis (HP:0001406) | 2.05291493 |
| 119 | Vomiting (HP:0002013) | 2.05056760 |
| 120 | Abnormality of eosinophils (HP:0001879) | 2.04834922 |
| 121 | Methylmalonic aciduria (HP:0012120) | 2.04221393 |
| 122 | Albinism (HP:0001022) | 2.02203816 |
| 123 | Hyperventilation (HP:0002883) | 2.02013912 |
| 124 | Insidious onset (HP:0003587) | 2.01491828 |
| 125 | Termporal pattern (HP:0011008) | 2.01491828 |
| 126 | Abolished electroretinogram (ERG) (HP:0000550) | 2.01357419 |
| 127 | Exertional dyspnea (HP:0002875) | 2.01297944 |
| 128 | Eosinophilia (HP:0001880) | 2.00563876 |
| 129 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99707149 |
| 130 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.99040787 |
| 131 | Exercise-induced myalgia (HP:0003738) | 1.98957994 |
| 132 | Lissencephaly (HP:0001339) | 1.97687313 |
| 133 | Autoimmune hemolytic anemia (HP:0001890) | 1.96648760 |
| 134 | Alkalosis (HP:0001948) | 1.96450398 |
| 135 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.96359288 |
| 136 | Hypoplasia of the fovea (HP:0007750) | 1.96359288 |
| 137 | Symptomatic seizures (HP:0011145) | 1.96278754 |
| 138 | Severe muscular hypotonia (HP:0006829) | 1.95810488 |
| 139 | Renal cortical cysts (HP:0000803) | 1.94654432 |
| 140 | Epidermoid cyst (HP:0200040) | 1.93477407 |
| 141 | Increased intramyocellular lipid droplets (HP:0012240) | 1.93349692 |
| 142 | Cavernous hemangioma (HP:0001048) | 1.91147121 |
| 143 | Conjugated hyperbilirubinemia (HP:0002908) | 1.91011730 |
| 144 | Autoimmune thrombocytopenia (HP:0001973) | 1.91010419 |
| 145 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.90592522 |
| 146 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.90592522 |
| 147 | Congenital, generalized hypertrichosis (HP:0004540) | 1.90253967 |
| 148 | Reduced antithrombin III activity (HP:0001976) | 1.89892461 |
| 149 | Delayed CNS myelination (HP:0002188) | 1.89881254 |
| 150 | Glycosuria (HP:0003076) | 1.89793753 |
| 151 | Abnormality of urine glucose concentration (HP:0011016) | 1.89793753 |
| 152 | Hyperglycemia (HP:0003074) | 1.89187790 |
| 153 | Sensory axonal neuropathy (HP:0003390) | 1.88715679 |
| 154 | Increased muscle lipid content (HP:0009058) | 1.88602964 |
| 155 | Stomatitis (HP:0010280) | 1.86839868 |
| 156 | Onion bulb formation (HP:0003383) | 1.86738527 |
| 157 | Hyperkalemia (HP:0002153) | 1.86276404 |
| 158 | Paralysis (HP:0003470) | 1.85497071 |
| 159 | Axonal loss (HP:0003447) | 1.85420141 |
| 160 | Retinal dysplasia (HP:0007973) | 1.85117232 |
| 161 | IgG deficiency (HP:0004315) | 1.84361359 |
| 162 | Hepatocellular carcinoma (HP:0001402) | 1.84319158 |
| 163 | Respiratory failure (HP:0002878) | 1.83586236 |
| 164 | Tubular atrophy (HP:0000092) | 1.82570257 |
| 165 | Birth length less than 3rd percentile (HP:0003561) | 1.82346017 |
| 166 | Fair hair (HP:0002286) | 1.81792856 |
| 167 | Abnormality of the fovea (HP:0000493) | 1.81697206 |
| 168 | Hypoalbuminemia (HP:0003073) | 1.81096049 |
| 169 | Abnormal albumin level (HP:0012116) | 1.81096049 |
| 170 | Hyperaldosteronism (HP:0000859) | 1.80209239 |
| 171 | Congenital sensorineural hearing impairment (HP:0008527) | 1.79774483 |
| 172 | Poor head control (HP:0002421) | 1.79123018 |
| 173 | Polycythemia (HP:0001901) | 1.78991997 |
| 174 | Constricted visual fields (HP:0001133) | 1.78604936 |
| 175 | Rhabdomyolysis (HP:0003201) | 1.78543307 |
| 176 | Optic disc pallor (HP:0000543) | 1.77387764 |
| 177 | Abnormality of potassium homeostasis (HP:0011042) | 1.77146361 |
| 178 | Brushfield spots (HP:0001088) | 1.76639887 |
| 179 | Abnormality of magnesium homeostasis (HP:0004921) | 1.76594710 |
| 180 | Furrowed tongue (HP:0000221) | 1.76029987 |
| 181 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.75850563 |
| 182 | Hyporeflexia of lower limbs (HP:0002600) | 1.74406397 |
| 183 | Cerebral edema (HP:0002181) | 1.73862840 |
| 184 | Muscle fiber atrophy (HP:0100295) | 1.73233850 |
| 185 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.72479779 |
| 186 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.72474886 |
| 187 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.72472297 |
| 188 | Visceral angiomatosis (HP:0100761) | 1.72090494 |
| 189 | Pancreatitis (HP:0001733) | 1.71295878 |
| 190 | Ileus (HP:0002595) | 1.70620418 |
| 191 | Lethargy (HP:0001254) | 1.70273143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 3.63415730 |
| 2 | ZAK | 3.61275984 |
| 3 | TRIB3 | 3.58846379 |
| 4 | WNK4 | 3.25121028 |
| 5 | ADRBK2 | 3.00937507 |
| 6 | BCKDK | 2.98562403 |
| 7 | STK39 | 2.96493586 |
| 8 | OXSR1 | 2.88372937 |
| 9 | EIF2AK3 | 2.69498485 |
| 10 | BMPR1B | 2.61843880 |
| 11 | CAMK1G | 2.53092569 |
| 12 | TRIM28 | 2.28634837 |
| 13 | PINK1 | 2.20403424 |
| 14 | MAP4K2 | 2.16498225 |
| 15 | MAP3K10 | 2.11978385 |
| 16 | CAMK1D | 2.06303750 |
| 17 | NUAK1 | 2.01919164 |
| 18 | ACVR1B | 1.98997668 |
| 19 | SIK1 | 1.95598612 |
| 20 | MST4 | 1.92449154 |
| 21 | FGFR2 | 1.83765744 |
| 22 | CAMKK2 | 1.78949584 |
| 23 | WNK1 | 1.77966362 |
| 24 | EIF2AK1 | 1.77661710 |
| 25 | TAOK3 | 1.76183735 |
| 26 | EPHB1 | 1.70972192 |
| 27 | GRK1 | 1.68732766 |
| 28 | TXK | 1.63367728 |
| 29 | SGK494 | 1.53971801 |
| 30 | SGK223 | 1.53971801 |
| 31 | PKN1 | 1.53921469 |
| 32 | NTRK1 | 1.49912297 |
| 33 | MET | 1.40614806 |
| 34 | RET | 1.40001617 |
| 35 | ERN1 | 1.38300872 |
| 36 | ERBB3 | 1.34042821 |
| 37 | MAPKAPK5 | 1.27659806 |
| 38 | WNK3 | 1.27463502 |
| 39 | HIPK2 | 1.27019928 |
| 40 | PRKAA2 | 1.26842377 |
| 41 | TIE1 | 1.26687809 |
| 42 | MUSK | 1.23645800 |
| 43 | VRK1 | 1.21147403 |
| 44 | BMPR2 | 1.20901462 |
| 45 | MARK3 | 1.19081938 |
| 46 | MAP3K7 | 1.12285186 |
| 47 | ADRBK1 | 1.08889690 |
| 48 | PLK2 | 1.08436919 |
| 49 | PDPK1 | 1.08372466 |
| 50 | TEC | 1.04592748 |
| 51 | OBSCN | 1.03862586 |
| 52 | PRKD1 | 1.02828114 |
| 53 | PKN2 | 1.02735751 |
| 54 | SGK3 | 1.00746682 |
| 55 | TLK1 | 0.99844941 |
| 56 | DAPK2 | 0.99377890 |
| 57 | PRKD3 | 0.97994258 |
| 58 | STK16 | 0.97206903 |
| 59 | PAK3 | 0.96732392 |
| 60 | PDK3 | 0.95644749 |
| 61 | PDK4 | 0.95644749 |
| 62 | UHMK1 | 0.95471256 |
| 63 | PIK3CA | 0.95358252 |
| 64 | IKBKB | 0.94775077 |
| 65 | MAP3K2 | 0.93800680 |
| 66 | MAPKAPK3 | 0.93771371 |
| 67 | PRKCH | 0.92714270 |
| 68 | PRKAA1 | 0.92698961 |
| 69 | CSNK1G2 | 0.92464996 |
| 70 | NTRK3 | 0.92154524 |
| 71 | PHKG1 | 0.91047019 |
| 72 | PHKG2 | 0.91047019 |
| 73 | AKT3 | 0.90479842 |
| 74 | MAP3K1 | 0.90211309 |
| 75 | FGFR4 | 0.89510213 |
| 76 | FLT3 | 0.87572640 |
| 77 | CDK9 | 0.85973898 |
| 78 | SRPK1 | 0.85214095 |
| 79 | CSNK1G3 | 0.84317815 |
| 80 | IRAK1 | 0.84149399 |
| 81 | MYLK | 0.83974166 |
| 82 | JAK2 | 0.83904011 |
| 83 | MAP3K12 | 0.83118359 |
| 84 | STK4 | 0.82471939 |
| 85 | MARK2 | 0.82196464 |
| 86 | CSNK1A1L | 0.81767517 |
| 87 | RPS6KA5 | 0.80990908 |
| 88 | SGK2 | 0.80723021 |
| 89 | NLK | 0.80257220 |
| 90 | MAPK13 | 0.79066999 |
| 91 | MAP2K1 | 0.76717269 |
| 92 | CDK6 | 0.76146207 |
| 93 | TAOK1 | 0.74217706 |
| 94 | SCYL2 | 0.73071089 |
| 95 | KSR2 | 0.72441960 |
| 96 | PDK1 | 0.72269523 |
| 97 | MAPK11 | 0.71426811 |
| 98 | PLK3 | 0.70887282 |
| 99 | BRSK2 | 0.70778831 |
| 100 | STK3 | 0.68660012 |
| 101 | CDK5 | 0.68169177 |
| 102 | PDGFRB | 0.66782510 |
| 103 | MAP2K4 | 0.66530948 |
| 104 | EPHA3 | 0.66328401 |
| 105 | STK38L | 0.64929984 |
| 106 | FRK | 0.64801656 |
| 107 | CDK19 | 0.64535283 |
| 108 | LRRK2 | 0.63984542 |
| 109 | STK11 | 0.63955607 |
| 110 | BCR | 0.63465755 |
| 111 | CSNK1G1 | 0.63435933 |
| 112 | TNIK | 0.63357457 |
| 113 | PTK6 | 0.62987842 |
| 114 | GRK7 | 0.62861704 |
| 115 | NEK9 | 0.62735306 |
| 116 | PRKCI | 0.62669952 |
| 117 | TRPM7 | 0.62338791 |
| 118 | CCNB1 | 0.62110973 |
| 119 | PRKCG | 0.61956081 |
| 120 | MAP3K4 | 0.61718615 |
| 121 | TGFBR1 | 0.60632227 |
| 122 | MAPK12 | 0.60248012 |
| 123 | CASK | 0.58388921 |
| 124 | MKNK2 | 0.57853038 |
| 125 | CAMK2B | 0.57225224 |
| 126 | PRKCE | 0.57060384 |
| 127 | SYK | 0.56991265 |
| 128 | PRKCQ | 0.56364698 |
| 129 | SGK1 | 0.55644726 |
| 130 | GRK6 | 0.54493371 |
| 131 | MST1R | 0.51307286 |
| 132 | MAP2K6 | 0.50462451 |
| 133 | CDK8 | 0.50407556 |
| 134 | DMPK | 0.48477960 |
| 135 | PRKACG | 0.48418555 |
| 136 | PTK2B | 0.48153526 |
| 137 | MARK1 | 0.47455955 |
| 138 | PRKD2 | 0.47061838 |
| 139 | IRAK2 | 0.45949002 |
| 140 | FGFR3 | 0.45691709 |
| 141 | PIK3CG | 0.45568548 |
| 142 | MAPK15 | 0.45439668 |
| 143 | CLK1 | 0.45362893 |
| 144 | PTK2 | 0.44916503 |
| 145 | PNCK | 0.44301469 |
| 146 | KDR | 0.44078269 |
| 147 | FES | 0.42347852 |
| 148 | JAK1 | 0.42235812 |
| 149 | GSK3A | 0.42234821 |
| 150 | BTK | 0.42066382 |
| 151 | FER | 0.41924586 |
| 152 | DYRK2 | 0.40478378 |
| 153 | LMTK2 | 0.40369320 |
| 154 | PDGFRA | 0.40325986 |
| 155 | FYN | 0.39871725 |
| 156 | CAMK2D | 0.39144447 |
| 157 | PDK2 | 0.38945378 |
| 158 | MAP2K7 | 0.37985563 |
| 159 | EIF2AK2 | 0.37467587 |
| 160 | ITK | 0.37019381 |
| 161 | ABL2 | 0.36529409 |
| 162 | TAF1 | 0.36262430 |
| 163 | ZAP70 | 0.34983501 |
| 164 | LCK | 0.32110992 |
| 165 | LIMK1 | 0.32088490 |
| 166 | IGF1R | 0.31348288 |
| 167 | ILK | 0.30993851 |
| 168 | KIT | 0.29671061 |
| 169 | GRK5 | 0.29552139 |
| 170 | IKBKE | 0.29287479 |
| 171 | ABL1 | 0.28420436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.34842654 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.20682406 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.15247612 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.97598921 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.83963520 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.72714482 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.65234605 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.64100434 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.49683756 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.43839680 |
| 11 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.23260348 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20579782 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 2.17204174 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.13519100 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.12390495 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.12345884 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.09771647 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 2.07416212 |
| 19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.00742470 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.98203391 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.96001496 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.91505224 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.87015198 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.84590219 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.81648680 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.81593086 |
| 27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.78736320 |
| 28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.76272663 |
| 29 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.62481090 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.58958730 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.58294436 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.57489436 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.57337021 |
| 34 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.51749116 |
| 35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.50342948 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.50201920 |
| 37 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.49871054 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41172746 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.40734469 |
| 40 | RNA degradation_Homo sapiens_hsa03018 | 1.40078050 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.38484608 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.38432931 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.33866561 |
| 44 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.32017853 |
| 45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.29837723 |
| 46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23515577 |
| 47 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.22117995 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 1.22002318 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.21570342 |
| 50 | Huntingtons disease_Homo sapiens_hsa05016 | 1.20443902 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20266879 |
| 52 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.18851953 |
| 53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15660992 |
| 54 | Purine metabolism_Homo sapiens_hsa00230 | 1.13772624 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.11144747 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.07510793 |
| 57 | Asthma_Homo sapiens_hsa05310 | 1.07083738 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 1.05821210 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05708671 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 1.05374327 |
| 61 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.05225691 |
| 62 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04751436 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 1.00320175 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.99928577 |
| 65 | Allograft rejection_Homo sapiens_hsa05330 | 0.96900322 |
| 66 | Olfactory transduction_Homo sapiens_hsa04740 | 0.95407105 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95005318 |
| 68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.94779086 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.92717410 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.92283402 |
| 71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91541160 |
| 72 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.90350700 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90252115 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88983396 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87803691 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.87239523 |
| 77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.87173267 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.85501131 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.85469630 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80955133 |
| 81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.80648777 |
| 82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80559860 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79407381 |
| 84 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.75947026 |
| 85 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75804424 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75574761 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73450636 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72620752 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71599337 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69509915 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.67675200 |
| 92 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.67601444 |
| 93 | Taste transduction_Homo sapiens_hsa04742 | 0.67143885 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62912402 |
| 95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61929803 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.61597655 |
| 97 | Renin secretion_Homo sapiens_hsa04924 | 0.61051208 |
| 98 | RNA transport_Homo sapiens_hsa03013 | 0.60346105 |
| 99 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60097365 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59612533 |
| 101 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.58856451 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58277036 |
| 103 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58193950 |
| 104 | Insulin secretion_Homo sapiens_hsa04911 | 0.57072436 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56985146 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56443385 |
| 107 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52961707 |
| 108 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52555870 |
| 109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52164983 |
| 110 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49861456 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49580858 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49197712 |
| 113 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48468150 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47128144 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46478716 |
| 116 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45045891 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44315196 |
| 118 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44185131 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44105764 |
| 120 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42854106 |
| 121 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.42535322 |
| 122 | Morphine addiction_Homo sapiens_hsa05032 | 0.41597516 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41144801 |
| 124 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40873908 |
| 125 | Parkinsons disease_Homo sapiens_hsa05012 | 0.39886679 |
| 126 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39150026 |
| 127 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.39088056 |
| 128 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.38590378 |
| 129 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.36800175 |
| 130 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.36784562 |
| 131 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.36246006 |
| 132 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.35896697 |
| 133 | Alzheimers disease_Homo sapiens_hsa05010 | 0.34696395 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34416535 |
| 135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34199667 |
| 136 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34102875 |
| 137 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33363333 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33239485 |
| 139 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33084438 |
| 140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32677518 |
| 141 | Alcoholism_Homo sapiens_hsa05034 | 0.32507303 |
| 142 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.32395757 |
| 143 | GABAergic synapse_Homo sapiens_hsa04727 | 0.30167192 |
| 144 | Ribosome_Homo sapiens_hsa03010 | 0.30125951 |
| 145 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28913096 |
| 146 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.27604216 |
| 147 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.27407860 |
| 148 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.26682424 |
| 149 | Protein export_Homo sapiens_hsa03060 | 0.26566040 |
| 150 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26547510 |
| 151 | Salivary secretion_Homo sapiens_hsa04970 | 0.25940906 |
| 152 | Mineral absorption_Homo sapiens_hsa04978 | 0.25633910 |
| 153 | Glioma_Homo sapiens_hsa05214 | 0.25264598 |
| 154 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24948983 |
| 155 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.24560524 |
| 156 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.24321693 |
| 157 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.18905358 |
| 158 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.18595533 |

